Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Genomics plc revenue
Genomics plc's revenue is $3.8 million.
What is Genomics plc's revenue?
- Genomics plc has 91 employees, and the revenue per employee ratio is $41,758.
- Genomics plc peak revenue was $3.8M in 2024.
On this page
Zippi applies for you, and finds you a job.
Genomics plc financing
Genomics plc received early financing of $16.2M on 2014-11-26.
| Series | Round size | Date |
|---|---|---|
| Series A | $16.2M | 11/2014 |
| Grant | $2.4M | 03/2015 |
| Series B | $30M | 08/2018 |
| Series B | $8.3M | 12/2018 |
| Series Unknown | $30M | 03/2021 |
Genomics plc investors
| Investors | Security type |
|---|---|
| University of Oxford | Series A |
| Lansdowne Partners | Series A |
| Invesco Ltd. | Series A |
| Woodford Investment Management | Series A |
| IP Group plc | Series A |
| INNOVATE UK | Grant |
| Oxford Sciences Innovation | Series B |
| TANARRA CREDIT PARTNERS PTY | Series B |
| Lansdowne Partners | Series B |
| Vertex Pharmaceuticals Incorporated | Series B |
| IP Group plc | Series B |
| Invesco Perpetual | Series B |
| Woodford Investment Management | Series B |
| Oxford Sciences Innovation | Series B |
| TANARRA CREDIT PARTNERS PTY | Series B |
| F-Prime Capital | Series B |
| Foresite Capital | Series B |
| Lansdowne Partners | Series B |
| Invesco Perpetual | Series B |
| IP Group plc | Series B |
| Woodford Investment Management | Series B |
| Vertex Pharmaceuticals Incorporated | Series B |
| Oxford Sciences Innovation | Series Unknown |
| F-Prime Capital | Series Unknown |
| Foresite Capital | Series Unknown |
| Lansdowne Partners | Series Unknown |
Genomics plc competitors
Genomics plc's top competitor, Inozyme Pharma, earned an annual revenue of $2.2B.
Genomics plc's smallest competitor is AptamiR with revenue of $130.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Centrillion Biosciences | - | $2.4M | 45 | - |
| LifeMine | - | $1.4M | 108 | - |
| Fate Therapeutics | - | $13.6M | 104 | - |
| Deciphera Pharmaceuticals | - | $163.4M | 200 | - |
| KSQ Therapeutics | - | $2.6M | 60 | - |
| Tmunity | - | $5.0M | 126 | - |
| ResQ Pharma | - | $740,000 | 30 | - |
| Inozyme Pharma | - | $2.2B | 20 | - |
| Celltheon | - | $440,000 | 2 | - |
| QuanDx | - | $5.0M | 5 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Genomics plc highest paying jobs
Zippia gives an in-depth look into the details of Genomics plc, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Genomics plc. The employee data is based on information from people who have self-reported their past or current employments at Genomics plc. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Genomics plc. The data presented on this page does not represent the view of Genomics plc and its employees or that of Zippia.
Genomics plc may also be known as or be related to GENOMICS PLC, Genomics Plc and Genomics plc.